SANTA CLARA, Calif. - HeartBeam, Inc. (NASDAQ: BEAT), een medisch technologiebedrijf met een huidige marktkapitalisatie van ongeveer $60 miljoen, heeft de prijsstelling van haar publieke aandelenuitgi ...

SANTA CLARA, Californië - HeartBeam, Inc. (NASDAQ: BEAT), een pionier in medische technologie met een marktkapitalisatie van $56,5 miljoen die momenteel handelt tegen $2,12 per aandeel, heeft ...

SANTA CLARA, Calif. - HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company with a current market capitalization of ...

HeartBeam (NASDAQ: BEAT), a medical technology company focused on cardiac care, announced the pricing of its public offering of 5,882,353 shares at $1.70 per share, expecting to raise $10 million ...

Despite a net loss and cash constraints, HeartBeam Inc (BEAT) remains optimistic about FDA clearance and its groundbreaking ECG technology. As the U.S. stock market experiences a downturn ...

Failed to fetch dynamically imported module: https://uk.finance.yahoo.com/assets/_app/immutable/nodes/106.BfLtBoPo.js ...

SANTA CLARA, Calif. - HeartBeam, Inc. (NASDAQ: BEAT), a $56.5 million market cap pioneer in medical technology currently trading at $2.12 per share, has announced the submission of a 510(k) ...

SANTA CLARA, Calif., February 13, 2025--HeartBeam Announces Pricing of $10.0 Million Underwritten Public Offering of Common Stock As the U.S. stock market navigates a mixed landscape of earnings ...

HeartBeam, Inc, a medical technology company, primarily focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease ...